This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2000-2001.
Company Filing History:
Years Active: 2000-2001
Title: Mythili Raman: Innovator in Pharmaceutical Development
Introduction
Mythili Raman is a prominent inventor based in Mumbai, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for the treatment of diabetes mellitus. With a total of 2 patents to her name, her work is recognized for its potential impact on healthcare.
Latest Patents
One of her latest patents is for Mumbaistatin, a compound that serves as a glucose-6-phosphate translocase inhibitor. This invention includes a detailed process for its production and its application as a pharmaceutical. Mumbaistatin is derived from the cultivation of the microorganism HIL-008003 (DSM 11641). The patent outlines its use in treating diabetes mellitus, along with the pharmaceutical compositions that incorporate Mumbaistatin or its pharmaceutically acceptable salts and derivatives. Additionally, she has developed Kodaistatins A, B, C, and D, which also includes a process for their production and use.
Career Highlights
Mythili Raman is currently associated with Aventis Pharma Deutschland, GmbH, where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and improving patient outcomes through effective pharmaceutical solutions.
Collaborations
Mythili has collaborated with notable colleagues in her field, including Herbert Kogler and Dietmar Schummer. These partnerships have contributed to her success and the advancement of her research initiatives.
Conclusion
Mythili Raman's contributions to pharmaceutical innovation, particularly in diabetes treatment, highlight her role as a leading inventor in the industry. Her patents reflect a dedication to improving healthcare through scientific advancements.